Top compounds associated with response to ACTL9


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.16 0.002
mRNA NU-7441 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.096 0.002
mRNA BEC CTRPv2 pan-cancer AAC 0.21 0.003
mRNA 681640 GDSC1000 pan-cancer AAC -0.11 0.003
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.097 0.004
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.095 0.006
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.093 0.008
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.092 0.01
mRNA Axitinib GDSC1000 pan-cancer AAC -0.09 0.01
Download CSV